2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress

Author's Avatar
Nov 07, 2022

2seventy+bio%2C+Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today reported financial results and recent highlights for the third quarter ended September 30, 2022.